Enhancing Cardiac Rehabilitation Attendance After Secondary Myocardial Infarction Through Clinician Messaging and Motivational Calls

Starting soon · Not applicable

Conditions studied: Type 2 Myocardial Infarction

In brief

The goal of this clinical trial is to determine if a behavioral intervention can increase attendance at cardiac rehabilitation (CR) after secondary/type 2 myocardial infarction in adult patients. The main question it aims to answer is: * Does the ATTEND-CR intervention increase attendance at ≥1 CR exercise session within 140 days of randomization? * Does the intervention increase completion of ≥12 CR exercise sessions within 140 days of randomization? Researchers will compare participants receiving the ATTEND-CR intervention (clinician notifications and a motivational interviewing participant phone call) to usual care to see if attendance and completion of CR improve. Participants: * Clinicians will receive informational messaging regarding CR and the referral process * Participate in a motivational interviewing phone call (intervention group only) * Have follow-up assessments via telephone and electronic health record (EHR) review to track CR attendance, clinical events, and health outcomes

Key facts

Study ID

NCT07485491

Run by

Massachusetts General Hospital

People needed

60

Starts

2026-06-01

Expected to finish

2028-04-01

Last updated by the study team

2026-03-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years
• Inpatient at MGH with an index secondary (type 2) MI
• Primary care provider (PCP) within the Mass General Brigham (MGB) network with at least one visit in the past 2 years
• Anticipated ability to ambulate independently without walking aids or supplemental ambulatory oxygen at discharge
• Ability to provide informed consent

You may not qualify if…

• Known severe untreated valvular heart disease or severe prosthetic valve dysfunction
• Known hypertrophic obstructive cardiomyopathy
• End-stage heart failure (VAD, transplant patient, or undergoing evaluation for VAD or transplant)
• Hemodynamic instability at the time of pre-screening
• Terminal illness with life expectancy < 1 year
• Severe anemia (hemoglobin < 8 g/dL) at the time of pre-screening
• Active, unstable cancer (excluding non-metastatic skin cancer) or currently receiving intensive cancer therapy
• Advanced kidney disease requiring renal replacement therapy
• Receiving palliative or comfort care only
• Recurrent falls (≥2) or falls with injury in the past year
• Physical or cognitive impairment likely to prevent safe participation in exercise over the next 5 months (e.g., significant stroke deficits, dementia)
• High-risk for non-adherence to study requirements
• Incarcerated individuals
• Currently pregnant or within 3 months postpartum
• Previously referred to or participated in CR within the past year
• Alternative MI subtype (spontaneous [type 1 MI] or procedural MI [type 4 or 5 MI]) in the past 6 months
• Suspected or confirmed coronary mechanism of index MI (vasospasm, embolism, or spontaneous coronary artery dissection)
• Anticipated discharge or discharged before enrollment measures can be completed
• Anticipated discharge to a facility where independent participation in CR is not feasible
• Previously enrolled in or declined participation in this study

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.